Protagonist Therapeutics (PTGX) Tax Rate (2018 - 2026)
Protagonist Therapeutics (PTGX) posted Tax Rate of 65.85% for Q1 2026, down 4222.46% sequentially from 1.52% in Q4 2025.
Powered by 
Analysis
Protagonist Therapeutics (PTGX) Tax Rate (2018 - 2026) Analysis & Trends
Protagonist Therapeutics has reported Tax Rate for 7 years, with the latest figure at 65.85% in Q1 2026.
- Quarterly Tax Rate changed N/A year-over-year to 65.85% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.55% (down 103.0% YoY) and the FY2025 annual result came in at 0.65%, down 216.0% from the prior year.
- Tax Rate fell to 65.85% in Q1 2026 per PTGX's latest filing, from 1.52% in the prior quarter.
- Over five years, Tax Rate peaked at 2.24% in Q2 2024 and troughed at 65.85% in Q1 2026.
- A 4-year average of 15.26% and a median of 0.34% in 2024 frame the typical range for Tax Rate.
- The sharpest annual moves came in 2024 and 2025: Tax Rate surged 6217 bps in 2024, then slumped 303 bps in 2025.
- Over 4 years, Tax Rate stood at 60.65% in 2023, then soared by 102 bps to 1.51% in 2024, then plunged by 201 bps to 1.52% in 2025, then plunged by 4222 bps to 65.85% in 2026.
- According to Business Quant data, Tax Rate over the past three periods registered 65.85%, 1.52%, and 0.58% for Q1 2026, Q4 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -10.89% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 24.15% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 7.49% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -16.71% |
| 10 | Protagonist Therapeutics | 9.61 Bn | 9.61 Bn | - | 1.39% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.39% |
| Mar 31, 2026 | -65.85% |
| Dec 31, 2025 | 61.90% |
| Jun 30, 2025 | -0.58% |
| Dec 31, 2024 | 42.23% |
| Sep 30, 2024 | 1.25% |
| Jun 30, 2024 | 2.24% |
| Mar 31, 2024 | 1.58% |
| Dec 31, 2023 | -60.65% |
| Jun 30, 2020 | -6.17% |
| Mar 31, 2020 | -1.00% |
| Dec 31, 2019 | -5.09% |
| Sep 30, 2019 | 0.62% |
| Jun 30, 2019 | 5.29% |
| Mar 31, 2019 | -1.31% |
| Dec 31, 2018 | 5.46% |